title: Contemporary minimally invasive treatment options for renal angiomyolipomas.
abstract: Renal angiomyolipomas (AMLs) are benign renal masses that are often asymptomatic and detected incidentally. However, treatment might be necessary in symptomatic presentations or when the mass exceeds 4 cm in size. While the goal of management for renal AMLs is to relieve symptoms and prevent hemorrhage, a priority is renal function preservation, especially given the propensity of these lesions to recur. The traditional treatment for renal AMLs is renal angioembolization or surgical excision of the lesion. With advancements in minimally invasive surgery, several other modalities have now emerged for nephron sparing approaches. These include angioembolization, laparoscopic and percutaneous ablative therapies such as radiofrequency ablation, cryoablation and microwave ablation, and pure or robot-assisted laparoscopic partial nephrectomy. Given the relatively low frequency of renal AMLs requiring treatment, much of the available literature on these minimally invasive approaches is largely extrapolative, based on series on small renal masses, i.e. renal cell carcinoma (RCC). This report is based on a thorough review of the published literature to date on the minimally invasive treatment and outcomes of renal AMLs.
authors: University of Wisconsin-Madison, Madison, WI, USA.
authors: Sri
authors: S
authors: Sivalingam
authors: Stephen Y
authors: SY
authors: Nakada
mesh_terms: D018207:Angiomyolipoma / Q000601:surgery* / Q000628:therapy; D017115:Catheter Ablation; D003452:Cryosurgery; D004621:Embolization, Therapeutic; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery* / Q000628:therapy; D010535:Laparoscopy; D008872:Microwaves / Q000627:therapeutic use; D009392:Nephrectomy; D016896:Treatment Outcome
references: Clin Radiol. 2008 Aug;63(8):864-70
references: 18625350
references: Urology. 1998 Oct;52(4):577-83
references: 9763074
references: Clin Nephrol. 1998 May;49(5):281-6
references: 9617489
references: J Urol. 1987 Sep;138(3):477-81
references: 3625844
references: Can Assoc Radiol J. 1997 Jun;48(3):191-8
references: 9193419
references: J Vasc Interv Radiol. 2005 Jan;16(1):45-50
references: 15640409
references: J Urol. 2002 Oct;168(4 Pt 1):1315-25
references: 12352384
references: J Urol. 2008 Sep;180(3):836-43
references: 18635231
references: Eur Urol. 2013 Apr;63(4):759-65
references: 22925574
references: J Urol. 1996 Jan;155(1):252-4; discussion 254-5
references: 7490847
references: J Endourol. 2010 Apr;24(4):583-7
references: 20423289
references: J Surg Oncol. 2012 Sep 1;106(3):316-21
references: 22488716
references: Urology. 2008 Nov;72(5):1077-82
references: 18805573
references: BJU Int. 2012 Feb;109(3):384-7
references: 22176671
references: Semin Ultrasound CT MR. 1997 Apr;18(2):100-14
references: 9163829
references: J Urol. 1986 Jun;135(6):1121-4
references: 3520013
references: AJR Am J Roentgenol. 2000 Mar;174(3):635-40
references: 10701601
references: J Vasc Interv Radiol. 2009 Sep;20(9):1224-9
references: 19616970
references: Eur Urol. 2009 Jan;55(1):199-207
references: 18684555
references: Urology. 2008 Jul;72(1):188-91
references: 18455777
references: Arch Esp Urol. 2012 Nov;65(9):831-4
references: 23154607
references: Kidney Int. 2004 Sep;66(3):924-34
references: 15327383
references: BJU Int. 2010 Jan;105(1):101-6
references: 19493268
references: J Urol. 2011 Sep;186(3):921-7
references: 21791345
references: Curr Opin Urol. 2006 Sep;16(5):321-6
references: 16905975
references: J Vasc Interv Radiol. 2010 Jan;21(1):67-72
references: 20123192
references: J Urol. 2003 Jan;169(1):49-53; discussion 53
references: 12478100
references: Radiology. 1997 Jul;204(1):65-70
references: 9205224
references: J Urol. 2006 Oct;176(4 Pt 1):1512-6; discussion 1516
references: 16952669
references: Urology. 2009 Dec;74(6):1246-9
references: 19815260